ARCHIVES

In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles

This article is from The Cancer Letter archive.

Vol. 09 No. 42 | November 4, 1983

Download PDF Visit The Full Archive

Related Articles

Two Drugs Combined Better Than One Alone, Study Finds

February 27, 2009

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

Chemo+Radiation Preserves Voice, RTOG Study Finds

December 26, 2003

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004